Non-Constipating, Bioavailable Bisglycinate Chelate
Iron is an essential mineral required for oxygen transport, immune system function, energy production, and neurologic development. When linked to the amino acid glycine, the resulting compounds, ferrous bisglycinate and ferric trisglycinate, provide well-tolerated sources of iron that are more bioavailable than other common forms of supplemental iron such as ferrous sulfate and ferrous gluconate.
Chelated iron formulated for enhanced absorption that's gentle on your stomach and non-constipating.
Research indicates that ferrous bisglycinate is better absorbed and tolerated than other iron preparations. Ferrochel® chelated iron is formulated for enhanced absorption of this essential mineral. Unlike many iron preparations, Iron Chelate is also well tolerated, gentle on the stomach, and non-constipating. Safe for use in adults, teenagers, and pregnant and lactating women when there is a demonstrated requirement for iron supplementation. Iron Chelate supplies 30 mg of elemental iron per capsule. Made with non-GMO and Kosher ingredients.
Product Features:
Serving Size: 1 Capsule |
Amount/Serving |
Iron (as TRAACS® and Ferrochel® ferrous bisglycinate chelate‡) | 30 mg |
Other Ingredients: Microcrystalline cellulose, vegetarian capsule (hydroxypropyl methylcellulose, water), ascorbyl palmitate, and silicon dioxide.
Made without common allergens: milk/casein, eggs, fish, shellfish, tree nuts, peanuts, wheat, gluten, yeast, soybeans, and sesame. No synthetic colors or flavors. Non-GMO, Vegan.
‡Albion®, TRAACS®, and Ferrochel® are registered trademarks of Albion® Laboratories, Inc.
Adults: 1 capsule daily with food or as directed by a healthcare professional. Not intended for children.
Caution: Consult with your physician if you are pregnant or nursing, or have a medical condition, or taking prescription drugs, or under the age of 18 years. KEEP OUT OF REACH OF CHILDREN.
Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under the age of 6. KEEP OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
In recent years, clinical research on iron bioavailability and tolerance has focused on segments of the population with increased iron requirements: premenopausal women, pregnant women, and people with disrupted digestive function and absorption.
A recent clinical trial illustrates the superior bioavailability and tolerance of iron bisglycinate as compared to ferrous sulfate. In a trial involving 124 premenopausal females with decreased iron status, just 21 mg/day of ferrous bisglycinate liquid over 12 weeks was shown to be as effective as higher amounts of ferrous sulfate (324 mg/day, providing 65 mg/day of elemental iron) at promoting healthy iron levels. In addition, participants receiving ferrous bisglycinate reported improved tolerance, with significantly fewer episodes of gastrointestinal upset.
Similarly, in a trial of 80 healthy pregnant women, those receiving just 25 mg/day of oral ferrous bisglycinate had statistically equivalent iron levels at the conclusion of the trial compared with participants receiving 50 mg/day of ferrous sulfate. Once again, participants receiving ferrous bisglycinate reported fewer gastrointestinal complaints.
In addition to superior bioavailability and tolerance, iron chelate is rapidly absorbed. In a 2016 clinical trial, children with disrupted digestive function and depleted serum iron doubled their baseline iron levels within three hours after ingesting oral ferrous bisglycinate chelate, in all but one participant.
Conclusion
Iron bisglycinate and ferric trisglycinate are safe and effective supplements to promote healthy iron status. When compared to other common forms of supplemental iron, iron chelate demonstrates superior bioavailability and tolerability.
Mechanisms of action: